The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Schwieterman William D since year 2005.
The trader's CIK number is 1403961.
At the time of this reporting, Schwieterman William D is the President and CEO of Mateon Therapeutics Inc .
(stock ticker symbol MATN).
See this page for all insider trading activities at Mateon Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-04-12||MATN||Mateon Therapeutics Inc||Buy||625,000||.00||0|
|2014-06-23||CHTP||Chelsea Therapeutics International, Ltd.||Option Ex||350,000||3.00||1,051,050|
|2011-11-23||CHTP||Chelsea Therapeutics International, Ltd.||Buy||45,141||4.46||201,328|
|2011-03-07||CHTP||Chelsea Therapeutics International, Ltd.||Buy||40,000||3.96||158,400|
|2009-05-14||CHTP||Chelsea Therapeutics International, Ltd.||Buy||19,301||2.72||52,498|
|2009-05-13||CHTP||Chelsea Therapeutics International, Ltd.||Buy||11,150||2.48||27,652|
|2009-05-12||CHTP||Chelsea Therapeutics International, Ltd.||Buy||15,000||2.47||37,050|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schwieterman William D (President and CEO of Mateon Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.